Grand Angels Gets New President Amid Growing Activity

Tim Parker to Lead Michigan’s Leading Angel Network, Organization Deploys $3.5 Million during 2016 HOLLAND, Mich., November 16, 2016,— MVCA member Grand Angels, Michigan’s leading angel investment network today announced Timothy Parker has become the organization’s second president in the 13-year history of the organization. Parker officially succeeded Jody Vanderwel, following a unanimous vote of the… read more

Plymouth Ventures invests in Indianapolis-based Cloud Technology Provider, Kinney Group

Indianapolis, IN (November 9, 2016) – Plymouth Ventures announced today that it has made a growth round investment in Kinney Group, Inc. (KGI), a cloud solutions integrator serving the Global 2000, IT-centric mid-market companies, and US Public Sector organizations. The participation from Plymouth is a strategic part of KGI’s overall fundraising objective for helping accelerate… read more

Evan Ufer, Up and Coming Award!

Evan Ufer began his career as an architect, at one of the nation’s largest architecture firms.  Although Ufer no longer helps to build companies in their physical form, he now assists in the development of companies as a partner at Plymouth Ventures.  His ability to identify strong, Michigan-based investment opportunities; provide deal leadership and connections… read more

BERINGEA CO-LEADS $15.2 MILLION SERIES F ROUND IN PORTFOLIO COMPANY INCONTEXT SOLUTIONS

Intel’s strategic investment and M&A group Intel Capital is new investor in company FARMINGTON HILLS, MICH. (October 26, 2016)— Beringea, Michigan VC firm and MVCA member, and Intel Capital co-led a $15.2 million funding round for portfolio company InContext Solutions, a global leader in virtual reality (VR) solutions for retailers and manufacturers.  The capital will help… read more

MVCA Members Join the Judging Panel at AMIC

Michigan Venture Capital Association members are lending their expertise to the judging panels at the 2016 Accelerate Michigan Innovation Competition (AMIC) on November 3.  AMIC, one of the Presenting Sponsors at the 2016 MVCA Annual Awards Dinner, is Michigan’s premier business plan competition and highlights the state as a powerhouse for business opportunity and next… read more

Strengthening Collaboration Between Startups & Automotive Industry in Detroit

On Dec 11, 2014, Bill Ford introduced Techstars Mobility to the world: the first startup accelerator program in North America to focus on the future of mobility, automotive, and transportation. You can watch part of this announcement here. Since then, we’ve been on a mission to connect the automotive and startup worlds by breaking down… read more

2016 MVCA Annual Awards Dinner

Investors and Entrepreneurs Moving Michigan Forward ANN ARBOR (October 12, 2016)—Michigan Venture Capital Association (MVCA) will host its 2016 Annual Awards Dinner, the largest gathering of venture investors and entrepreneurs in Michigan, on November 2 at the Rattlesnake Club in Detroit.  Honorees include Millendo Therapeutics with the Capital Event of the Year Award, Fontinalis Partners with the… read more

Congratulations Emily Heintz, 40 under 40 Awardee!

Emily Heintz joined MVCA three years ago with a mandate to help support Michigan’s vibrant entrepreneurial and venture capital community.  A natural networker and people person, Emily expanded the educational and networking events the organization offers and grew the popular talent programs.   And perhaps most significantly, Emily, a data guru at heart, transformed the MVCA… read more

RetroSense Therapeutics, Exit of the Year!

The team at RetroSense Therapeutics, seasoned veterans with experience taking medical technology from the discovery stage to the clinic, knew 2016 could be a breakout year for the company.  RetroSense’s therapy, based on research conducted at Wayne State University in Detroit, was almost ready for its biggest test yet: a Phase I/II clinical trial.  In… read more

Millendo Therapeutics, Capital Event of the Year!

Finding drugs to improve the quality of life for patients with endocrine diseases with few or no treatment options, can be a noble but resource-intensive task.  For Ann Arbor-based Millendo Therapeutics, a $62 million Series B financing announced in January 2016 moved the biotechnology company a little closer to that goal and earned it the… read more